14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.397
+0 (+0%)
At Close: Feb 28, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Feb 28, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 27, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 24, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 23, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 22, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 21, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 17, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 16, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 15, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 14, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 13, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 10, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 09, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 08, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 07, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 06, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 03, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 02, 2023 $0.397 $0.397 $0.397 $0.397 0
Feb 01, 2023 $0.397 $0.397 $0.397 $0.397 0
Jan 31, 2023 $0.397 $0.397 $0.397 $0.397 0
Jan 30, 2023 $0.397 $0.397 $0.397 $0.397 0
Jan 27, 2023 $0.397 $0.397 $0.397 $0.397 0
Jan 26, 2023 $0.397 $0.397 $0.397 $0.397 0
Jan 25, 2023 $0.397 $0.397 $0.397 $0.397 0
Jan 24, 2023 $0.397 $0.397 $0.397 $0.397 0
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT